Skip to main content

Dulaglutide

FDA recalls

2 rows

DateCompany and reasonClass
Apr 4, 2022Cardinal Health Inc.
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions		Class II · Completed
Aug 18, 2021Eli Lilly & Company
Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.		Class II · Terminated

← Back to Dulaglutide

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).